Major
Probable
Description
Spironolactone increases renal lithium reabsorption by promoting distal tubular sodium retention, leading to lithium toxicity.
Mécanisme
Spironolactone antagonizes aldosterone-mediated distal tubular sodium excretion; the resulting sodium retention reduces compensatory proximal tubular sodium (and lithium) reabsorption variably, but overall lithium levels tend to rise.
Signification clinique
Lithium toxicity has been documented with spironolactone co-administration; the direction and magnitude of interaction is variable.
Prise en charge
Monitor lithium levels within 1 week of spironolactone initiation or dose change; adjust lithium dose based on levels.